Table 2 The concentrations of serum anti-PLA2R-IgG in different nephropathy diseases.

From: A novel Time-resolved Fluoroimmunoassay for the quantitative detection of Antibodies against the Phospholipase A2 Receptor

 

Healthy volunteers (n = 45)

IgA nephropathy (n = 31)

lupus nephropathy (n = 9)

other kidney disease n = 9

iMN (n = 52)

mean ± SD (mg/L)

0.53 ± 0.18

0.70 ± 0.41

1.08 ± 0.65

0.42 ± 0.20

9.00 ± 11.82

positive rates

0

29.0%

44.4%

0

88.5%

Back to article page